NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Zhejiang Shapuaisi Pharmaceutical Co.Ltd (SHG: 603168)
603168 Technical Analysis
2
As on 21st Nov 2024 603168 STOCK Price closed @ 8.78 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.78 & Buy for SHORT-TERM with Stoploss of 8.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
603168STOCK Price
Open | 8.50 | Change | Price | % |
High | 8.97 | 1 Day | 0.58 | 7.07 |
Low | 8.40 | 1 Week | 0.17 | 1.97 |
Close | 8.78 | 1 Month | 0.84 | 10.58 |
Volume | 26892419 | 1 Year | 0.04 | 0.46 |
52 Week High 15.36 | 52 Week Low 6.04 |
SHG China Most Active Stocks
600157 | 1.64 | -2.96% |
600221 | 1.78 | -1.66% |
600839 | 13.41 | 10.01% |
601727 | 10.08 | 2.34% |
601162 | 5.13 | 1.79% |
600811 | 3.23 | -2.42% |
600050 | 5.37 | -2.01% |
601360 | 13.09 | 10.00% |
600518 | 2.40 | -1.23% |
600010 | 1.92 | -1.03% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
603168 Daily Charts |
603168 Intraday Charts |
Whats New @ Bazaartrend |
603168 Free Analysis |
|
603168 Important Levels Intraday
RESISTANCE | 9.88 |
RESISTANCE | 9.53 |
RESISTANCE | 9.31 |
RESISTANCE | 9.09 |
SUPPORT | 8.47 |
SUPPORT | 8.25 |
SUPPORT | 8.03 |
SUPPORT | 7.68 |
603168 Forecast November 2024
4th UP Forecast | 11.23 |
3rd UP Forecast | 10.44 |
2nd UP Forecast | 9.96 |
1st UP Forecast | 9.47 |
1st DOWN Forecast | 8.09 |
2nd DOWN Forecast | 7.6 |
3rd DOWN Forecast | 7.12 |
4th DOWN Forecast | 6.33 |
603168 Weekly Forecast
4th UP Forecast | 10.01 |
3rd UP Forecast | 9.62 |
2nd UP Forecast | 9.37 |
1st UP Forecast | 9.13 |
1st DOWN Forecast | 8.43 |
2nd DOWN Forecast | 8.19 |
3rd DOWN Forecast | 7.94 |
4th DOWN Forecast | 7.55 |
603168 Forecast2024
4th UP Forecast | 27.86 |
3rd UP Forecast | 21.74 |
2nd UP Forecast | 17.96 |
1st UP Forecast | 14.18 |
1st DOWN Forecast | 3.38 |
2nd DOWN Forecast | -0.4 |
3rd DOWN Forecast | -4.18 |
4th DOWN Forecast | -10.3 |
Zhejiang Shapuaisi Pharmaceutical Co.Ltd ( SHG China Symbol : 603168 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
603168 Other Details
Segment | EQ | |
Market Capital | 2958177792.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
603168 Address
603168 Latest News
603168 Business Profile
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, liver disease adjuvant, cardiovascular, detoxification, diuretic row stone, gynecology, infusion, and jianweixiaosh categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, suppositories, granules, medicine raw materials, rinsing agents, mixtures, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China. Address: No. 1588 Xinming Road, Pinghu, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service